12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Other News

Alchemia cancer news

Alchemia delayed plans to spin out its U.S. subsidiary Audeo Oncology Inc. (San Francisco, Calif.) and list it on U.S. and Australian exchanges. The company said it was unable to secure new investments at terms...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >